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The cDNA clone encoding human leukotriene A., hydrolase was inserted into a vector pUC9 and expressed in Escherichiu 
cob’ as a fusion protein containing the first 10 amino acid residues derived from a vector. The leukotriene A4 hydrolase 
activity was recovered in the soluble fraction of the transformants. The purified enzyme showed kinetic properties imilar 
to the native enzyme, including inactivation by the substrate and sulfhydryl-modifying reagents. The results demonstrate 
that a protein with an M, of 70000 was expressed in Escherichia colt with a full enzyme activity and structural fidelity. 
Acquisition of the expression system makes it feasible to elucidate the reaction mechanism of the enzyme. 
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1. INTRODUCTION 
Leukotrienes are a group of bioactive com- 
pounds involved in inflammation and hypersen- 
sitivity reactions [1,2]. An allylic epoxide 
intermediate, LT&, is synthesized from 
arachidonic acid by the action of 5-lipoxygenase 
[3-81. LT& hydrolase which synthesizes a 
chemotactic compound, LTB4, was purified from 
various sources [g-12]. The enzyme is inactivated 
by its substrate (suicide-type inactivation) and also 
by SH-modifying reagents [121. Recently, a cDNA 
for LT& hydrolase was cloned and characterized 
from human spleen and placental ibraries [ 13,141. 
The mature enzyme consists of 610 amino acids, 
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[13,14]. To elucidate the reaction mechanism of 
the enzyme, the cDNA for LT& hydrolase was ex- 
pressed in Escherichia c&i. The protein product 
possessed a full enzyme activity and various 
properties identical to the native enzyme. 
2. MATERIALS AND METHODS 
2.1. Materials 
Restriction enzymes were purchased from Takara Shuzo Co. 
(Kyoto). The Klenow fragment of DNA polymerase I, and an 
expression vector pUC9 were obtained from Amersham. E. co/i 
YA 21 was a kind gift of Dr H. Furukawa (Sankyo Co., Ltd, 
Tokyo). Other reagents were of the highest grade available. 
2.2. Construction of the vector for expression 
The expression plasmids were constructed from cDNA 
recombinant clones pLTA851 and pLTA858 as described in 
fig. 1. The cDNA insert of pLTA851, which corresponds to the 
N-terminal 350 amino acid residues of human LT& hydrolase 
[13], was cut out with AvuI and EcoRI, and then ligated to a 
pUC9 plasmid vector digested with both HincII and EcoRI to 
obtain a clone (referred to as pEX851) according to the method 
of Maniatis et al. [IS]. pLTA858, a clone encoding the residual 
C-terminal region of the enzyme (351-610 residues) (131, was 
digested with EcoRI, and the resulting 827 bp-fragment was in- 
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serted into pEX85 1 digested with EcoRI to obtain an expression 
plasmid referred to as pEX85 (fig.1). 
2.3. Purification of LTA4 hydrolase xpressed in E. coli 
pEX85 was used to transform E. coli YA 21, by the method 
of Hanahan 1161. The transformant was cultured in the M9 
medium containing 0.2% casamino acid and 75/g/ml am- 
picillin at 37°C for 1 h. Then, IPTG was added to a final con- 
centration of 1 mM, and the incubation was continued for 
another 2 h. Cells were collected by centrifugation (10000 x g, 
10 min) and suspended in buffer A (50 mM Tris-HCl, 5 mM 
EDTA, 5 mM 2-mercaptoethanol, 1 mM phenyhnethylsulfonyl 
fluoride and 2pg/ml leupeptin, pH 8). The suspension was 
sonicated three times at output control 3 for 1 min with a Bran- 
son sonifier model 185. To the supernatant (centrifugation at 
10000 x g, 15 min), solid ammonium sulfate was added. The 
precipitate formed between 40 and 70% saturation was dissolv- 
ed in buffer A and dialyzed three times against 250 volumes 
each of the same buffer. The dialyzed sample was purified by 
Mono-Q and Mono-P column chromatographies (Pharmacia, 
Uppsala), as described [13]. 
2.4. N-terminal seguence analysis 
Active fractions from a Mono-P column were applied to a 
Phenyl-5PW column (0.75 x 5 cm, Tosoh, Tokyo), and eluted 
with a linear gradient consisting of 20 ml each of 0.1% 
trifluoroacetic acid in water and 0.1% trifluoroacetic acid in 
acetonitrile. The N-terminal sequence of the expressed product 
was determined using a gas-phase amino acid sequencer model 
470A (Applied Biosystems). 
2.5. Miscellaneous 
The assay of LT& hydrolase and the identification of the 
reaction product were carried out as described in [12]. SDS- 
polyacrylamide gel electrophoresis was performed by the 
method of Laemmli [17]. The protein concentration was deter- 
mined by the method of Lowry et al. [18] with bovine serum 
albumin as a standard. 
3. RESULTS AND DISCUSSION 
E. coli YA 21 transformed with pEX85 overex- 
pressed a protein with an A4, of 70000 (hereafter 
referred to as EXSS). As shown in fig.2, EX85 was 
recovered in the supernatant obtained by cen- 
trifugation (10000 x g, 10 min) of the sonicated 
suspension of the transformant (lane 2). The 
amount of EX85 in the supernatant increased up to 
2 h after IPTG induction, but thereafter emained 
constant, while EX85 in the precipitate increased 
time-dependently, as assessed by SDS-poly- 
acrylamide gel electrophoresis (not shown). This 
finding suggests that LT& hydrolase is relatively 
resistant o proteolytic digestion or encapsulation 
to the inclusion bodies of the bacteria, for at least 
2 h. Since the supernatant possessed the LTA4 
hydrolase activity, it was further purified ac- 
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Fig.1. Construction of plasmid pEX85 for the synthesis of 
LT& hydrolase in E. coli. pLTA851, a clone encoding the N- 
terminal 350 amino acid residues of human LTA.+ hydrolase 
[13] was cut out with EcoRI after being digested with Aval and 
filled-in with the Klenow fragment. The EcoRI fragment was 
ligated to a pUC9 plasmid vector digested with both WincII and 
EcoRI to obtain pEX851. pLTA858, a clone encoding the 
residual C-terminal region of the enzyme (351-610 residues) 
[13], was digested with EcoRI, and the resulting 827 bp 
fragment was inserted into the EcoRI-digested pEX851 to 
obtain pEX85. A and E are AvaI and EcoRI sites abbreviated, 
respectively. 
cording to the methods described in section 2. 
From a 3 1 culture, 3 mg of EX85 was obtained 
using Mono-Q and Mono-P column chroma- 
tographies (lanes 3 and 4). The expressed protein 
(EX85) has a similar electrophoretic mobility to 
the native enzyme from human lung (lane 5). 
Overall purification was about lOO-fold with a 
yield of 120-250%. A prominent increase in the 
total activity (2-5-fold) was observed after the am- 
monium sulfate fractionation. This might be due 
either to the removal of inhibitory factor(s) present 
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Fig.2. SDS-polyacrylamide gel electrophoresis of the fusion 
protein EX85. Protein preparations obtained from coli, 
E. coli extracts or to a conformational adjust- 
ment during this step. Human LT& hydrolase has 
been purified from neutrophils [9] and lung [ 121 by 
4 steps of column chromatography with yields of 
12% and lo%, respectively [9,12]. Therefore, 
LT& hydrolase is more efficiently obtained with a 
much higher yield from the transformant. The N- 
terminal sequence analysis of EX85 revealed that it 
contained 10 amino acids derived from pUC9 
(Thr-Met-Ile-Thr-Pro-Ser-Leu-Ala-Ala-Gly), fol- 
lowed by the N-terminal sequence (Pro-Glu-Ile- 
Val-Asp-Thr) reported for the enzymes from 
human neutrophils and lung [9,12]. 
The Km value of EX85 for LT& was 27 PM, and 
the Vmax value was 4.3 bmol LTBJmin - mg. These 
values are comparable with those of human 
neutrophils [9], lung [12] and rat neutrophils [lo]. 
Fig.3 shows the time course of the LTB4 synthesis 
by the purified enzyme (EX85). The reaction 
almost reached a plateau in 30 s. The rapid 
deceleration of the enzyme reaction was not due to 
the depletion of substrate LT&, since the initial 
velocity of the reaction was recovered by the addi- 
Fig.3. The time course of the enzymic hydration of LT& by the 
fusion protein EX85. EX85 (2ag/lO$) was incubated with 
LT& (20 /tM) in 50 pl of 0.1 M Tris-HCI @H 7.8) ‘containing 
2 mg/ml bovine serum albumin at 37°C for 5 min (o--o). 
After the 30 s incubation (indicated by the arrow), EX85 (B) or 
LT& (A) was further added to the reaction mixture. 
tion of the enzyme, and not of the substrate. This 
phenomenon is known as the suicide-type inactiva- 
tion of LT& hydrolase, caused by its substrate, 
LT& [11,12]. 
SH-modifying reagents, NEM, PCMB and 
HgClz, inhibited the activity of LT& hydrolase. 
The ICSO values of NEM, PCMB and HgCl2 were 
1 mM, 0.02pM and O.O26pM, respectively. In- 
hibition by those SH-modifying reagents has 
already been noted for the native LT& hydrolase 
purified from human lung [12]. 
All these results provide direct evidence that 
clone LTA85 [ 131 encodes human LT& hydrolase. 
It was also demonstrated that a protein with an Mr 
of 70000 was expressed in E. coli with full enzyme 
activity and high structural fidelity to the native 
enzyme. The acquisition of the expression system 
makes it feasible to elucidate the reaction 
mechanism of the enzyme, and to synthesize a 
substantial amount of LTB4, a biologically active 
compound. 
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